Osteoarthritis (OA) is a degenerative disease characterized by progressive articular cartilage destruction and joint marginal osteophyte formation with different degrees of synovitis. Docosahexaenoic acid (DHA) is an unsaturated fatty acid with anti-inflammatory, antioxidant, and antiapoptotic functions. In this study, the human chondrosarcoma cell line SW1353 was cultured in vitro, and an OA cell model was constructed with inflammatory factor IL-1β stimulation. After cells were treated with DHA, cell apoptosis was measured. Western blot assay was used to detect protein expression of apoptosis-related factors (Bax, Bcl-2, and cleaved caspase-3) and mitogen-activated protein kinase (MAPK) signaling pathway family members, including extracellular signal-regulated kinase (ERK), c-JUN N-terminal kinase (JNK), and p38 MAPK. Our results show that IL-1β promotes the apoptosis of SW1353 cells, increases the expression of Bax and cleaved caspase-3, and activates the MAPK signaling pathway. In contrast, DHA inhibits the expression of IL-1β, inhibits IL-1β-induced cell apoptosis, and has a certain inhibitory effect on the activation of the MAPK signaling pathway. When the MAPK signaling pathway is inhibited by its inhibitors, the effects of DHA on SW1353 cells are weakened. Thus, DHA enhances the apoptosis of SW1353 cells through the MAPK signaling pathway.

Keywords:
Apoptosis, Docosahexaenoic acid, MAPK, Osteoarthritis, SW1353
1.
Arshad A, Chung WY, Steward W, Metcalfe MS, Dennison AR: Reduction in circulating pro-angiogenic and pro-inflammatory factors is related to improved outcomes in patients with advanced pancreatic cancer treated with gemcitabine and intravenous omega-3 fish oil. HPB (Oxford) 15:428-432 (2013).
2.
Berquin I, Edwards I, Chen Y: Multi-targeted therapy of cancer by omega-3 fatty acids. Cancer Lett 269:363-377 (2008).
3.
Calder PC: Docasahexaenoic acid. Ann Nutr Metab 69:8-21 (2016).
4.
Das M, Das S: Identification of cytotoxic mediators and their putative role in the signaling pathways during docosahexaenoic acid (DHA)-induced apoptosis of cancer cells. Apoptosis 21:1408-1421 (2016).
5.
D'Eliseo D, Pisu P, Romano C, Tubaro A, De Nunzio C, et al: Granzyme B is expressed in urothelial carcinoma and promotes cancer cell invasion. Int J Cancer 127:1283-1294 (2010).
6.
du Toit-Kohn JL, Louw L, Engelbrecht AM: Docosahexaenoic acid induces apoptosis in colorectal carcinoma cells by modulating the PI3 kinase and p38 MAPK pathways. J Nutr Biochem 20:106-114 (2009).
7.
Fluckiger A, Dumont A, Derangère V, Rébé C, de Rosny C, et al: Inhibition of colon cancer growth by docosahexaenoic acid involves autocrine production of TNFα. Oncogene 35:4611-4622 (2016).
8.
Giunta S, Castorina A, Marzagalli R, Szychlinska MA, Pichler K, et al: Ameliorative effects of PACAP against cartilage degeneration. Morphological, immunohistochemical and biochemical evidence from in vivo and in vitro models of rat osteoarthritis. Int J Mol Sci 16:5922-5944 (2015).
9.
Gonzalez MJ, Schemmel RA, Dugan LJ, Gray JI, Welsch CW: Dietary fish oil inhibits human breast carcinoma growth: a function of increased lipid peroxidation. Lipids 28:827-832 (1993).
10.
Gu Z, Wu J, Wang S, Suburu J, Chen H, et al: Polyunsaturated fatty acids affect the localization and signaling of PIP3/AKT in prostate cancer cells. Carcinogenesis 34:1968-1975 (2013).
11.
Huang LH, Chung HY, Su HM: Docosahexaenoic acid reduces sterol regulatory element binding protein-1 and fatty acid synthase expression and inhibits cell proliferation by inhibiting pAkt signaling in a human breast cancer MCF-7 cell line. BMC Cancer 17:890 (2017).
12.
Jeong S, Jing K, Kim N, Shin S, Kim S, et al: Docosahexaenoic acid-induced apoptosis is mediated by activation of mitogen-activated protein kinases in human cancer cells. BMC Cancer 14:481 (2014).
13.
Jhawer M, Goel S, Wilson AJ, Montagna C, Ling YH, et al: PIK3CA mutation/PTEN expression status predicts response of colon cancer cells to the EGFR inhibitor cetuximab. Cancer Res 68:1953-1961 (2008).
14.
Kato T, Kolenic N, Pardini RS: Docosahexaenoic acid (DHA), a primary tumor suppressive omega-3 fatty acid, inhibits growth of colorectal cancer independent of p53 mutational status. Nutr Cancer 58:178-187 (2007).
15.
Kim N, Jeong S, Jing K, Shin S, Kim S, et al: Docosahexaenoic acid induces cell death in human non-small cell lung cancer cells by repressing mTOR via AMPK activation and PI3K/Akt inhibition. Biomed Res Int 2015:239764 (2015).
16.
Lee SE, Lim JW, Kim H: Activator protein-1 mediates docosahexaenoic acid-induced apoptosis of human gastric cancer cells. Ann N Y Acad Sci 1171:163-169 (2009).
17.
Leroy B, Girard L, Hollestelle A, Minna JD, Gazdar AF, Soussi T: Analysis of TP53 mutation status in human cancer cell lines: a reassessment. Hum Mutat 35:756-765 (2014).
18.
Li D, Liu N, Zhao HH, Zhang X, Kawano H, et al: Interactions between Sirt1 and MAPKs regulate astrocyte activation induced by brain injury in vitro and in vivo. J Neuroinflammation 14:67 (2017).
19.
Lièvre A, Bachet JB, Le Corre D, Boige V, Landi B, et al: KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer. Cancer Res 66:3992-3995 (2006).
20.
Little CB, Barai A, Burkhardt D, Smith SM, Fosang AJ, et al: Matrix metalloproteinase 13-deficient mice are resistant to osteoarthritic cartilage erosion but not chondrocyte hypertrophy or osteophyte development. Arthritis Rheum 60:3723-3733 (2009).
21.
Mehler SJ, May LR, King C, Harris WS, Shah Z: A prospective, randomized, double blind, placebo-controlled evaluation of the effects of eicosapentaenoic acid and docosahexaenoic acid on the clinical signs and erythrocyte membrane polyunsaturated fatty acid concentrations in dogs with osteoarthritis. Prostaglandins Leukot Essent Fatty Acids 109:1-7 (2016).
22.
Merendino N, Loppi B, D'Aquino M, Molinari R, Pessina G, et al: Docosahexaenoic acid induces apoptosis in the human PaCa-44 pancreatic cancer cell line by active reduced glutathione extrusion and lipid peroxidation. Nutr Cancer 52:225-233 (2005).
23.
Morin C, Fortin S: Docosahexaenoic acid monoglyceride increases carboplatin activity in lung cancer models by targeting EGFR. Anticancer Res 37:6015-6023 (2017).
24.
Oono K, Takahashi K, Sukehara S, Kurosawa H, Matsumura T, et al: Inhibition of PC3 human prostate cancer cell proliferation, invasion and migration by eicosapentaenoic acid and docosahexaenoic acid. Mol Clin Oncol 7:217-220 (2017).
25.
Park M, Kim H: Anti-cancer mechanism of docosahexaenoic acid in pancreatic carcinogenesis: a mini-review. J Cancer Prev 22:1-5 (2017).
26.
Pizato N, Luzete BC, Kiffer LFMV, Corrêa LH, de Oliveira Santos I, et al: Omega-3 docosahexaenoic acid induces pyroptosis cell death in triple-negative breast cancer cells. Sci Rep 8:1952 (2018).
27.
Pogash TJ, El-Bayoumy K, Amin S, Gowda K, de Cicco RL, et al: Oxidized derivative of docosahexaenoic acid preferentially inhibit cell proliferation in triple negative over luminal breast cancer cells. In Vitro Cell Dev Biol Anim 51:121-127 (2015).
28.
Rogers KR, Kikawa KD, Mouradian M, Hernandez K, McKinnon KM, et al: Docosahexaenoic acid alters epidermal growth factor receptor-related signaling by disrupting its lipid raft association. Carcinogenesis 31:1523-1530 (2010).
29.
Sato SB, Park J, Kawamoto J, Sato S, Kurihara T: Inhibition of constitutive Akt (PKB) phosphorylation by docosahexaenoic acid in the human breast cancer cell line MDA-MB-453. Biochim Biophys Acta 1831:306-313 (2013).
30.
Schley PD, Jijon HB, Robinson LE, Field CJ: Mechanisms of omega-3 fatty acid-induced growth inhibition in MDA-MB-231 human breast cancer cells. Breast Cancer Res Treat. 92:187-195 (2005).
31.
Sen R, Hurley JA: Osteoarthritis. StatPearls (Internet). Treasure Island (FL): StatPearls Publishing (2018).
32.
Serini S, Trombino S, Oliva F, Piccioni E, Monego G, et al: Docosahexaenoic acid induces apoptosis in lung cancer cells by increasing MKP-1 and down-regulating p-ERK1/2 and p-p38 expression. Apoptosis 13:1172-1183 (2008).
33.
Silawal S, Triebel J, Bertsch T, Schulze-Tanzil G: Osteoarthritis and the complement cascade. Clin Med Insights Arthritis Musculoskelet Disord 11:1179544117751430 (2018).
34.
Song KS, Jing K, Kim JS, Yun EJ, Shin S, et al: Omega-3-polyunsaturated fatty acids suppress pancreatic cancer cell growth in vitro and in vivo via downregulation of Wnt/Beta-catenin signaling. Pancreatology 11:574-584 (2011).
35.
Spencer L, Mann C, Metcalfe M, Webb M, Pollard C, et al: The effect of omega-3 FAs on tumour angiogenesis and their therapeutic potential. Eur J Cancer 45:2077-2086 (2009).
36.
Sun Y, Jia X, Hou L, Liu X, Gao Q: Involvement of apoptotic pathways in docosahexaenoic acid-induced benefit in prostate cancer: pathway-focused gene expression analysis using RT2 profile PCR array system. Lipids Health Dis 16:59 (2017).
37.
Tasaki S, Horiguchi A, Asano T, Ito K, Asano T, Asakura H: Docosahexaenoic acid inhibits the phosphorylation of STAT3 and the growth and invasion of renal cancer cells. Exp Ther Med 14:1146-1152 (2017).
38.
Tylichová Z, Slavík J, Ciganek M, Ovesná P, Krčmář P, et al: Butyrate and docosahexaenoic acid interact in alterations of specific lipid classes in differentiating colon cancer cells. J Cell Biochem 119:4664-4679 (2018).
39.
VanderSluis L, Mazurak VC, Damaraju S, Field CJ: Determination of the relative efficacy of eicosapentaenoic acid and docosahexaenoic acid for anti-cancer effects in human breast cancer models. Int J Mol Sci 18:E2607 (2017).
40.
Wang YC, Wu YN, Wang SL, Lin QH, He MF, et al: Docosahexaenoic acid modulates invasion and metastasis of human ovarian cancer via multiple molecular pathways. Int J Gynecol Cancer 26:994-1003 (2016).
41.
Xue M, Wang Q, Zhao J, Dong L, Ge Y, et al: Docosahexaenoic acid inhibited the Wnt/β-catenin pathway and suppressed breast cancer cells in vitro and in vivo. J Nutr Biochem 25:104-110 (2014).
42.
Xue M, Ge Y, Yu C, Zheng Z, He X, Zhao J: Apoptosis is induced by docosahexaenoic acid in breast cancer cells via death receptor and mitochondria-mediated pathways. Mol Med Rep 16:978-982 (2017).
43.
Yin Y, Sui C, Meng F, Ma P, Jiang Y: The omega-3 polyunsaturated fatty acid docosahexaenoic acid inhibits proliferation and progression of non-small cell lung cancer cells through the reactive oxygen species-mediated inactivation of the PI3K/Akt pathway. Lipids Health Dis 16:87 (2017).
44.
Zhang G, Panigrahy D, Mahakian LM, Yang J, Liu JY, et al: Epoxy metabolites of docosahexaenoic acid (DHA) inhibit angiogenesis, tumor growth, and metastasis. Proc Natl Acad Sci USA 110:6530-6535 (2013).
© 2019 S. Karger AG, Basel
2019
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.